Saliba Group - Physiology and biochemistry of the malaria parasite

The Saliba Group is investigating vitamin utilisation pathways in the red blood cell stage of the human malaria parasite Plasmodium falciparum. We are investigating these pathways as potential drug targets for new antimalarials.

Filter by keyword

Publications

Striving toward malaria eradication, by Christina Spry

Striving toward malaria eradication, by Christina Spry

Story | Sunday 16 August 2020
Striving toward malaria eradication: Development of a single drug to kill malaria parasites and the mosquitoes that transmit them.
parasite kaledascope

Challenging the host-parasite binary

Story | Monday 10 August 2020
Tunan (Nicole) Yu discusses Horwitz and Wilcox (2005) and taking a multi-faceted view towards parasites to manage disease risk.

Kevin Saliba

Story | Wednesday 11 June 2014
Lab research

BSB Seminar Series: Nature's Toolbox - Unlocking Drug Discovery with Natural Products

Event | Thu 30 January 2025
Natural products have long been celebrated as a treasure trove of therapeutic agents, serving as the foundation for many life-saving drugs. This general talk outlines possible approaches to the discovery and development of small molecule therapeutics for the treatment of inflammation and infectious diseases.
Recorded BSB Seminar - Richard K Haynes

BSB Seminar Series: The Antimalarial Peroxide Artemisinin and Derivatives: Mechanism of Action - The "Heme Activation" Hypothesis vs. Oxidant Properties

Event | Thu 21 November 2024
Over 50 years ago, the active principle 青蒿素 qīng hāo sū or artemisinin was isolated in pure crystal-line form from the leaves of the Chinese traditional herb 青蒿 qīng hāo - Artemisia annua - by Chinese groups working under the remarkable Project 523 during the latter stages of the Chinese Cultural Revolution.
Recorded BSB Seminar - Imam Fathoni

BSB PhD Exit Seminar: Targeting Thiamine (Vitamin B1) Metabolism and Utilisation in Plasmodium

Event | Thu 18 July 2024
Malaria is a significant disease in Africa, certain countries in Asia, and Central and South America. In 2022, malaria infected approximately 233 million people and caused 608,000 death.

BSB PhD Exit Seminar: Characterising aspects of the CoA biosynthesis pathway in P. falciparum and T. gondii

Event | Thu 2 June 2022
Malaria is an ancient disease leading to the death of more than half a million people every year.

Feeling hot in here: thermotolerance and drug sensitivity in malaria parasites

Event | Fri 28 February 2020
Audrey Odom John, Chief of the Division of Infectious Diseases at Children’s Hospital of Philadelphia. A physician-scientist, Dr. John’s NIH-funded research has focused on Plasmodium falciparum malaria parasites, with a particular interest in targeting parasite metabolism to identify novel targets for drug development

Piezo channels: tension, tethers and transduction

Event | Thu 26 July 2018

Mechanosensitive channels are fundamental molecular components of mechanosensory systems in all organisms.

Updated:  3 March 2022/Responsible Officer:  Web Services/Page Contact:  Web Services